Health

Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.

Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.

The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.

Allison K. Hoffman discusses the role of state ballot initiatives, federal law, and private equity in the U.S. health care system.

OSHA should use machine learning to improve the effectiveness of its regulatory inspections.

Scholar calls for regulation to counter cigarette addiction while limiting increased vaping among non-smokers.

Medicaid expansion ballot initiatives show state referenda can expand health care access—but they have their limits.

Scholar calls on Congress to expand telehealth services in rural parts of the United States.

Scholars recommend regulators promote alternatives to experiments conducted on animals.

Scholars urge Congress to give FDA more power to regulate dietary supplements.

Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.

A recent report proposes state-level reforms to allow pharmacists to prescribe contraceptives.